MedTrace Logo

Fibroids in Women of Reproductive Age and Women Pregnancy

NCT02620345 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-12-03

No results posted yet for this study

Summary

Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.

Conditions

  • Fibroids

Interventions

DRUG

Dydrogesterone M ( case 1 )

Dydrogesterone Multivitamin nature * Fibroids / Women Pregnancy ( discovered fibroids during pregnancy ) Dydrogesterone Multivitamin nature. * 1tablet/24 hours/day (to 4 weeks after postpartum)

DRUG

Dydrogesterone M ( case 2 )

Dydrogesterone Multivitamin nature * Fibroids/ Women of Reproductive age ( discovered fibroids ) * 1tablet/24 hours/day ( from discovered fibroids through 6 months)

Sponsors & Collaborators

  • Trieu, Nguyen Thi, M.D.

    lead INDIV

Principal Investigators

  • Nguyen Thi Trieu, Master · Tran Minh Duc, Dr.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2015-10-31
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620345 on ClinicalTrials.gov